Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa

AIDS

Volumn 19, Issue 12, 2005, Pages 1273-1277

  Lombart, Jean Pierre ^a   Vray, Muriel ^b   Kafando, Anatole ^a   Lemée, Véronique ^c   Ouédraogo Traoré, Rasmata ^a   Corrigan, Gary E ^d   Plantier, Jean Christophe ^c   Simon, François ^c   Braun, Joséphine ^c  

^a CHU Charles De Gaulle   (Burkina Faso)

^b INSTITUT PASTEUR   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Africa; HIV; HIV diagnosis tests; HIV diversity; HIV 1 RNA; p24 antigen; Reverse transcriptase activity; Treatment monitoring

Indexed keywords

ANTIGEN P24; RNA DIRECTED DNA POLYMERASE;

ADOLESCENT; ADULT; AFRICA; ANALYSIS OF VARIANCE; ARTICLE; CHILD; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEAT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIREMIA; VIRION; VIRUS LOAD;

EID: 24044469077     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000180098.58017.48     Document Type: Article

References (22)

1. McCutchan FE. Understanding the genetic diversity of HIV-1. AIDS 2000; 14 (Suppl 3):S31-S44.
2. Peeters M, Sharp PM. Genetic diversity of HIV-1: the moving target. AIDS 2000; 14 (Suppl 3):S129-S140.
3. Braun J, Plantier JC, Hellot MF, Tuaillon E, Gueudin M, Damond F. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS 2003; 17:331-336.
4. Plantier JC, Gueudin M, Damond F, Braun J, Mauclere P, Simon F. Plasma RNA quantification and HIV-1 divergent strains. J Acquir Immune Defic Syndr 2003; 33:1-7.
5. Murphy DG, Cote L, Fauvel M, Rene P, Vincelette J. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2000; 38:4034-4041.
6. Nadal D, Boni J, Kind C, et al. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis 1999; 180:1089-1095.
7. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
8. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346:1085-1087.
9. Ouedraogo-Traore R, Montavon C, Sanou T, Vidal N, Sangare L, Sanou I, et al. CRF06-cpx is the predominant HIV-1 variant in AIDS patients from Ouagadougou, the capital city of Burkina Faso. Aids 2003; 17:441-442.
10. Burgisser P, Vernazza P, Flepp M, Boni J, Tomasik Z, Hummel U, et al. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2000; 23:138-144.
11. Lerma JG, Soriano V, Mas A, Quinones-Mateu ME, Arts EJ, Heneine W. Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity. J Clin Microbiol 2000; 38:402-405.
12. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259:1749-1754.
13. Layne SP, Merges MJ, Dembo M, Spouge JL, Conley SR, Moore JP, et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 1992; 189:695-714.
14. O'Doherty U, Swiggard WJ, Malim MH. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 2000; 74:10074-10080.
15. Fransen K, Beelaert G, van der Groen G. Evaluation of four HIV antigen tests. J Virol Methods 2001; 93:189-193.
16. Ribas SG, Ondoa P, Schupbach J, van der Groen G, Fransen K. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. J Virol Methods 2003; 113:29-34.
17. Sutthent R, Gaudart N, Chokpaibulkit K, Tanliang N, Kanoksinsombath C, Chaisilwatana P. p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol 2003; 41:1016-1022.
18. Pascual A, Cachafeiro A, Funk ML, Fiscus SA. Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay. J Clin Microbiol 2002; 40:2472-2475.
19. Stevens G, Rekhviashvili N, Scott LE, Gonin R, Stevens W. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa. J Clin Microbiol 2005; 43:857-861.
20. Bonard D, Rouet F, Toni TA, Minga A, Huet C, Ekoue DK, et al. Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Cote d'Ivoire, West Africa. J Acquir Immune Defic Syndr 2003; 34:267-273.
21. Gautier-Charpentier L, Ouedraogo-Traore R, Simonon A, Meda N, Kpozehouen A, Dahourou H, et al. Impact of human immunodeficiency virus type 1 subtype on HIV antibody detection in Burkina Faso. J Acquir Immune Defic Syndr 2001; 28:194-195.
22. Lyamuya E, Bredberg-Raden U, Massawe A, et al. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:421-426.